EPI 001

Known as: EPI-001, EPI001 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2010-2017
01220102017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Prostate cancer (PCa) is the 2nd leading cause of cancer-related death among men in the United States and its progression is… (More)
Is this relevant?
2017
2017
Prostate cancer (PC) is one of the leading causes of cancer death in men. It commonly develops in older males, but the number of… (More)
Is this relevant?
2016
2016
Castration-resistant prostate cancer is the lethal condition suffered by prostate cancer patients that become refractory to… (More)
Is this relevant?
Review
2016
Review
2016
The role of androgen receptor (AR) in the initiation and progression of prostate cancer (PCa) is well established. Competitive… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2015
2015
The androgen receptor (AR) is a driver of prostate cancer (PCa) cell growth and disease progression. Therapies for advanced PCa… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
2015
Review
2015
Reactivated androgen receptor (AR) signaling drives castration-resistant prostate cancer (CRPC). The novel AR targeting drugs… (More)
Is this relevant?
2014
2014
Androgen receptor signaling is critical in the development and progression of prostate cancer, leading to intensive efforts to… (More)
  • table 1
Is this relevant?
Highly Cited
2013
Highly Cited
2013
Hormone therapies for advanced prostate cancer target the androgen receptor (AR) ligand-binding domain (LBD), but these… (More)
  • figure 1
  • figure 4
  • figure 5
  • figure 6
  • figure 7
Is this relevant?
2010
2010
recurrent prostate cancer (CRPC) is generally believed to involve the androgen receptor (AR) in most patients. Current treatments… (More)
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Castration-recurrent prostate cancer (CRPC) is suspected to depend on androgen receptor (AR). The AF-1 region in the amino… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?